Haemonetics files 8-K for Q2 FY2023 results; filing lacks specific financial figures

HAEMONETICS CORP

2023-Q2 EPS reported $1.03 revenue$558,943,000

Company issued press release for Q2 ended October 1, 2022 and first half FY2023 results.
Filing only references Exhibit 99.1; actual financial data not included in provided text.
Confidence in event detail is low due to absence of numbers in this filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.